A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus

PLoS Pathogens

Volumn 7, Issue 2, 2011, Pages

  Feederle, Regina ^a   Linnstaedt, Sarah D ^b   Bannert, Helmut ^a   Lips, Helge ^a   Bencun, Maja ^a   Cullen, Bryan R ^b   Delecluse, Henri Jacques ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 2; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; MICRORNA; VIRUS RNA; BHRF1 PROTEIN, HUMAN HERPESVIRUS 4; MESSENGER RNA; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; BHRF1 GENE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL EXPANSION; CELL STRAIN HEK293; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRON; LYMPHOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; VIROGENESIS; VIRUS LOAD; WILD TYPE; CELL CULTURE; CELL CYCLE; CYTOLOGY; EPSTEIN BARR VIRUS INFECTION; GENETIC TRANSCRIPTION; GENETICS; KIDNEY; LUNG; METABOLISM; MUTATION; PATHOGENICITY; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS LATENCY; VIRUS REPLICATION; WESTERN BLOTTING;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

B-LYMPHOCYTES; BLOTTING, WESTERN; CELL CYCLE; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; KIDNEY; LUNG; LYMPHOMA; MICRORNAS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 79952206685     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001294     Document Type: Article

References (40)

1. Rickinson AB, Kieff E, (2007) Epstein-Barr virus, In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields Virology Philadelphia Lippincott Williams & Wilkins pp. 2655-2700.
2. Rickinson AB, Callan MF, Annels NE, (2000) T-cell memory: lessons from Epstein-Barr virus infection in man. Philos Trans R Soc Lond B Biol Sci 355: 391-400.
3. Hammerschmidt W, Sudgen B, (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B-lymphocytes. Nature 340: 393-397.
4. Cohen JI, Wang F, Mannick J, Kieff E, (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A 86: 9558-9562.
5. Mannick JB, Cohen JI, Birkenbach M, Marchini A, Kieff E, (1991) The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 65: 6826-6837.
6. Kaye KM, Izumi KM, Kieff E, (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90: 9150-9154.
7. Humme S, Reisbach G, Feederle R, Delecluse HJ, Bousset K, et al. (2003) The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci U S A 100: 10989-10994.
8. Lerner MR, Andrews NC, Miller G, Steitz JA, (1981) Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A 78: 805-809.
9. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, et al. (2004) Identification of virus-encoded microRNAs. Science 304: 734-746.
10. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, et al. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2: e23.
11. Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, et al. (2009) Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83: 2357-2367.
12. Hutzinger R, Feederle R, Mrazek J, Schiefermeier N, Balwierz PJ, et al. (2009) Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog 5: e1000547.
13. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
14. Kieff E, Rickinson AB, (2007) Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields Virology Philadelphia Lippincott Williams & Wilkins pp. 2603-2654.
15. Xing L, Kieff E, (2007) Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. J Virol 81: 9967-9975.
16. Neuhierl B, Delecluse HJ, (2005) Molecular genetics of DNA viruses: recombinant virus technology. Methods Mol Biol 292: 353-370.
17. Aubin J, Davi F, Nguyen-Salomon F, Leboeuf D, Debert C, et al. (1995) Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 9: 471-479.
18. Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, et al. (2009) An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathog 5: e1000341.
19. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
20. Cullen BR, (2009) Viral and cellular messenger RNA targets of viral microRNAs. Nature 457: 421-425.
21. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, et al. (2008) Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 36: 666-675.
22. Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, et al. (2008) MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454: 780-783.
23. Murphy E, Vanicek J, Robins H, Shenk T, Levine AJ, (2008) Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci U S A 105: 5453-5458.
24. Lei X, Bai Z, Ye F, Xie J, Kim CG, et al. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12: 193-199.
25. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, et al. (2007) Host immune system gene targeting by a viral miRNA. Science 317: 376-381.
26. Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, et al. (2008) EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68: 1436-1442.
27. Hutchings IA, Tierney RJ, Kelly GL, Stylianou J, Rickinson AB, et al. (2006) Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines. J Virol 80: 10700-10711.
28. Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B, (2009) The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 386: 387-397.
29. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141.
30. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
31. Shaw G, Morse S, Ararat M, Graham FL, (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. Faseb J 16: 869-871.
32. Pulvertaft RJV, (1964) Cytology of Burkitt's lymphoma (African lymphoma). Lancet 1: 238-240.
33. Takada K, Horinouchi K, Ono Y, Aya T, Osato T, et al. (1991) An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5: 147-156.
34. Clements GB, Klein G, Povey S, (1975) Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Int J Cancer 16: 125-133.
35. Hayflick L, (1965) The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res 37: 614-636.
36. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W, (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95: 8245-8250.
37. Griffin BE, Bjorck E, Bjursell G, Lindahl T, (1981) Sequence complexity of circular Epstein-Bar virus DNA in transformed cells. J Virol 40: 11-19.
38. Feederle R, Bannert H, Lips H, Muller-Lantzsch N, Delecluse HJ, (2009) The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication. J Virol 83: 4952-4962.
39. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179.
40. Bell AI, Groves K, Kelly GL, Croom-Carter D, Hui E, et al. (2006) Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 87: 2885-2890.